In-Depth: How full FDA approval would impact vaccine mandates, competition
In depth: The impact of full FDA approval
and last updated 2021-04-09 22:36:47-04
SAN DIEGO (KGTV) Pfizer could apply for full FDA approval of its COVID-19 vaccine as early as this month, and Moderna could follow soon after.
If regulators sign off, that status change would have significant impacts on vaccine mandates in workplaces and other experimental vaccine candidates still in development.
Currently, the three vaccines on the market only have an Emergency Use Authorization (EUA), meaning they are âauthorizedâ by the Food and Drug Administration but not âapproved.â
Alzheimer s Association Denies Conflict in Aducanumab Support medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
FDA s Janet Woodcock failed to stop the opioid epidemic
Drug manufacturers such as Purdue might have ignited the deadly opioid crisis. However, the FDA was instrumental in allowing the epidemic to play out.
Gerald Posner
Opinion contributor
When the Biden administration tapped Janet Woodcock as the acting commissioner of the Food and Drug Administration, it seemed a good pick. Woodcock had spent 23 years as chief of the Center for Drug Evaluation and Research, a unit the FDA describes as its “consumer watchdog in America’s health care system. The CEDR is tasked with making certain that drugs are “safe and effective,” and “that the health benefits outweigh known risks.”